At December 31, 2025, intangible assets, net consisted of the following (in thousands):


	Useful Life (Years)	Gross January 1, 2025		Additions		Impairment/ Disposal		Gross December 31, 2025		Accumulated Amortization			Net December 31, 2025
Indefinite lived assets:
Trademarks and licenses	N/A	$	4,050	$	1,900	$	—	$	5,950	$	—		$	5,950
Amortized intangible assets:
Network relationships	10–21		171,917		53,800		—		225,717		(125,359	)		100,358
Member relationships	7–14		73,077		123,500		—		196,577		(47,908	)		148,669
Other (1)	3–20		26,010		14,300		—		40,310		(24,319	)		15,991
		$	275,054	$	193,500	$	—	$	468,554	$	(197,586	)	$	270,968

(1)

Other consists of management contracts, a patient management platform, trade name/trademarks, and developed technology.

At December 31, 2024, intangible assets, net consisted of the following (in thousands):


	Useful Life (Years)	Gross January 1, 2024		Additions		Impairment/ Disposal		Gross December 31, 2024		Accumulated Amortization			Net December 31, 2024
Indefinite lived assets:
Trademarks and licenses	N/A	$	2,150	$	1,900	$	—	$	4,050	$	—		$	4,050
Amortized intangible assets:
Network relationships	10–21		150,679		21,238		—		171,917		(114,046	)		57,871
Member relationships	7–14		24,077		49,000		—		73,077		(22,406	)		50,671
Other (1)	5–20		26,010		—		—		26,010		(20,423	)		5,587
		$	202,916	$	72,138	$	—	$	275,054	$	(156,875	)	$	118,179

(1)

Other consists of management contracts, a patient management platform, trade name/trademarks, and developed technology.

As of December 31, 2025, network relationships, management contracts, member relationships, tradename/trademarks, and developed technology had weighted-average remaining useful lives of 12.0 years, 8.2 years, 18.9 years, 5.6 years, and 2.1 years, respectively. Total weighted average remaining useful lives for all amortized intangible assets as of December 31, 2025 was 15.6 years. Amortization expense was $40.7 million, $25.6 million, and $12.7 million for the years ended December 31, 2025, 2024, and 2023, respectively, which is included in depreciation and amortization in the accompanying consolidated statements of income.

There was no impairment loss recorded related to intangibles for the years ended December 31, 2025, 2024, and 2023.